Ultrasound Guided Pterygopalatine Fossa Block in Functional Endoscopic Sinus Surgery

Perioperative Outcome of Ultrasound Guided Pterygopalatine Fossa Block in Functional Endoscopic Sinus Surgery: A Randomized Controlled Trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202202836176096

Enrollment

120

Registered

2022-02-22

Start date

2022-03-01

Completion date

Unknown

Last updated

2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ear, Nose and Throat

Interventions

General anesthesia and Pterygopalatine Fossa Block

General anesthesia only

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: American Society of Anesthesiologists (ASA) class I or II scheduled for elective functional endoscopic sinus surgery (FESS).

Exclusion criteria

Exclusion criteria: History of allergy or contraindication to any of the studied drugs. Patients for whom pterygopalatine fossa block is contraindicated Patient refusal. Patients with fascial anomalies. Patients with coagulation abnormalities or on antiplatelet medication within the past 2 weeks Skin infection at the injection site Patient with invasive fungal sinusitis or revision surgery Obese patients with BMI more than 35 Kg/m2. Patient with allergic polyps on systemic steroids

Design outcomes

Primary

Measure	Time frame
Heart rate ;Mean arterial blood pressure	—

Secondary

Measure	Time frame
End tidal expired isoflurane concentration ;Total Fentanyl requirement	—

Countries

Egypt

Contacts

Public ContactElsayedamr Basma

Patient Information Manager

elsayedamr@yahoo.com00201223106023

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026